Transaction · 0001193125-26-384391

Civik Thomas

Civik Thomas, CEO, CHAIR, reported a transaction classified as grant at Pyxis Oncology, Inc. involving 2503050.000000 shares for an estimated $0.00. Reported holdings after the transaction were 2503050.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO, CHAIR
PYXSPyxis Oncology, Inc.
Filing timeSep 08
Trade dateSep 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.89
Pre-filing
1mo ago -19.5%1w ago -17.0%1d ago -8.5%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

PYXS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PYXS since 2026-09-08Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-384391
Stock Option (Right to Buy)
Transaction date
Sep 04, 2026
Filed Sep 08, 2026, 11:41 AM · 4d delay
Shares
2.50M sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
2.50M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO & Chairman of the Board

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of September 4, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subje…

Original filing · 0001193125-26-384391
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PYXS